Emma Groarke

Credentials: · ·

History

JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure
Principal investigator · Active not recruiting · Phase 1, Phase 2
National Heart, Lung, and Blood Institute (NHLBI)
2024–2032
Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
Principal investigator · Recruiting
National Heart, Lung, and Blood Institute (NHLBI)
2021–2041
Retrospective Study of Patients With Severe Aplastic Anemia Who Developed High Risk Clonal Evolution With Chromosome 7 Abnormalities After Immunosuppressive Therapy
Principal investigator · Completed
National Heart, Lung, and Blood Institute (NHLBI)
2020–2022
Retrospective Study of Patients With Severe Aplastic Anemia Who Relapsed After Immunosuppressive Therapy
Principal investigator · Completed
National Heart, Lung, and Blood Institute (NHLBI)
2020–2023